Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. - Test2 - elhamkhani - TriplyDB

Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

http://www.wikidata.org/entity/Q33386227

about

Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer Assessment, origin, and implementation of breath volatile cancer markers.The scent of disease: volatile organic compounds of the human body related to disease and disorder Quantitative analysis of volatile organic compounds released and consumed by rat L6 skeletal muscle cells in vitro Breath analysis in disease diagnosis: methodological considerations and applications.Advances in electronic-nose technologies developed for biomedical applications.Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.Noninvasive detection of lung cancer by analysis of exhaled breath.Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation.Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.Analysis of volatile organic compounds liberated and metabolised by human umbilical vein endothelial cells (HUVEC) in vitro.Unique volatolomic signatures of TP53 and KRAS in lung cells.Urinary Volatile Organic Compounds for the Detection of Prostate Cancer Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice.TD-GC-MS Investigation of the VOCs Released from Blood Plasma of Dogs with Cancer.Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles.A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines.Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.Gas signatures from Escherichia coli and Escherichia coli-inoculated human whole blood.Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties More than apples and oranges--detecting cancer with a fruit fly's antenna Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns Blood volatile compounds as biomarkers for colorectal cancer.Volatile metabolomic signature of human breast cancer cell lines.Lung cancer biomarkers in exhaled breath.Noninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis.Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease.Classification of lung cancer histology by gold nanoparticle sensors.Hybrid volatolomics and disease detection.Nanoscale Sensor Technologies for Disease Detection via Volatolomics.Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.Advanced online monitoring of cell culture off-gas using proton transfer reaction mass spectrometry.Quantification by SIFT-MS of acetaldehyde released by lung cells in a 3D model.A study of enzymatic activity in cell cultures via the analysis of volatile biomarkers.Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's "chemical odor fingerprint".Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.Exhaled gases online measurements for esophageal cancer patients and healthy people by proton transfer reaction mass spectrometry.Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.

P2860

Q24817107-13FE621D-4359-4E4D-A2E6-32969F782B41 Q26796389-48E5697F-89B5-44E6-8475-5CA2A66A10F8 Q27692565-D60B604D-D716-427B-826F-C3C0C49A6503 Q28243639-C7A2B699-27BA-489C-BB9D-094D39CB5F12 Q28601030-F65C1054-CAC3-469A-9AFE-2FD7FFF40198 Q30434697-56E6672F-F68E-49CD-8473-6E837914F769 Q30470504-CB99F00C-4971-49DB-A8C2-203350D045E8 Q33435548-8491CE2E-8DDD-4802-B0CA-1674AEAF6552 Q33507435-A0036264-C886-43DF-AC0E-7434639C4716 Q34310915-ECED029C-5B93-4884-8AE9-54B3B52F5771 Q34648188-2190C2FC-BD0A-49DA-AA10-32861C1E708C Q34840709-EC9D4905-3C5A-4E21-987B-6392F54A5A06 Q34900602-9DF2C355-63EA-4E37-A84D-0B97608AC956 Q35678408-BE949DAE-DBF9-4E72-925B-331630DFEF1A Q35849909-9095EF73-1FC2-45CD-96DC-1E16E1666A2E Q35854350-EF5699D8-4DE5-4D13-A42A-ED5CAD240628 Q35911795-5A4757D4-F3D6-4279-987B-3750074D27BA Q36011615-7C6035EF-529F-42C3-9C40-B42933EEBFB3 Q36012613-1AE24DD3-CD12-40FE-93E9-FC4655F19E2C Q37001025-70CEDD7D-29DF-48A0-B06A-C09342AD7283 Q37028444-A3EDD64C-7BDA-4EE8-9EF1-ED3D64509074 Q37138493-9AE9B7AA-9F51-400E-B510-A174CF36A180 Q37434154-D310C14D-B891-4B75-89DD-89DAC75CFA62 Q37467282-48951176-F7C0-4EEC-B570-725DECDED8B3 Q37591469-E538922B-C9DF-4D74-A17E-99DEEAAC88EA Q37678902-285E520D-DBC9-4F37-9DCE-CAF414A4EDBE Q37853184-40319619-5F94-4A14-825E-04D59EA538EC Q38112480-79794CE8-A1E6-4E78-8681-10CD54B861F1 Q38182688-24671E63-828D-4A8D-9A4A-88BC5AADEC39 Q38286916-254EF704-B986-4FE2-8225-BF808F5E4441 Q38559382-6D2A4FE7-2508-4A78-9FB8-E20ECC7571B9 Q38602462-1F1F2206-56F6-404F-AC68-C49A45F2CEFB Q38779486-9F0B3049-7732-4250-AEBA-6A650EDDDD99 Q39038574-ECF1C412-0005-4BED-BE18-30FD8EC76573 Q39247847-9A9B3DC8-FE42-4C82-AF37-59657A15969E Q39289143-31049EFD-E438-4B11-AB77-496463406072 Q39367135-3C0555B1-B36F-4A4F-9E9A-5781B70AAD0E Q39893495-E140E375-951D-46C2-AD08-9FFBE7F1FAFA Q39904147-33920970-ADFC-4118-B47D-3017B7CA1BC7 Q41577330-90D729BC-6F99-4D72-B25A-A65DAF1C4A6B

P2860

Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

http://www.wikidata.org/entity/Q33386227

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Release of volatile organic co ...... cer cell line CALU-1 in vitro.

@ast

Release of volatile organic co ...... cer cell line CALU-1 in vitro.

@en

type

label

Release of volatile organic co ...... cer cell line CALU-1 in vitro.

@ast

Release of volatile organic co ...... cer cell line CALU-1 in vitro.

@en

prefLabel

Release of volatile organic co ...... cer cell line CALU-1 in vitro.

@ast

Release of volatile organic co ...... cer cell line CALU-1 in vitro.

@en

P1433

Q33386227-1A8E3564-905B-427C-8239-FA539C2F736D

P1476

Q33386227-AD0A2AB2-B5BF-4CF8-9FB9-8FF0AB929E70

P2093

Q33386227-303A7168-B9ED-424D-8ABC-1D47CF1CAC16

Q33386227-5928EBF4-71C8-4A98-83FD-BC52932CE4C8

Q33386227-637AF5FD-968E-49A3-A6AA-0C648646FCCF

Q33386227-6831A7F4-872C-44DC-BB9F-3F114BB1876D

Q33386227-CAEEFE31-1942-4CB3-BB89-3CE273A60227

P2860

Q33386227-0B4AE3C7-A745-488C-A252-D7F3B3E8B03D

Q33386227-0C0AAA52-D4A2-4DB0-AE0B-5F2C3789DF33

Q33386227-1265E60F-4C19-4476-BC60-9DBCD29B56A1

Q33386227-1735133D-1307-45B7-862A-1A4C6BC8134B

Q33386227-2477F6DF-C873-4487-89EC-77580E584F8E

Q33386227-457FFA96-59FF-431B-B797-748A0881CAA1

Q33386227-56A03BFC-6C3D-47EC-BEF4-141152F4BF0D

Q33386227-79E69ADF-A978-46B7-AAF9-EB1A0EE63FA3

Q33386227-9D7BBF42-92B5-4A5A-BD84-A942A44B1660

Q33386227-A74587E2-A255-4BA6-9A24-3140CEFAB205

P2888

Q33386227-13C489C7-CEBE-43B7-BA10-8D256FF2ADAE

P304

Q33386227-2BD188B7-6B8D-43E6-9B4A-A53BB4425BDC

P31

Q33386227-16B6B7D7-7B11-4EF1-AB21-CBF6920AC64B

P356

Q33386227-6DB524DD-35E9-4705-BF2C-45A9C6B680E9

P478

Q33386227-E9E13B9C-F2A9-4EDC-89D2-843338D51AE2

P50

Q33386227-712D8259-6985-4C4B-A40D-08626D04B2C5

Q33386227-729A32C7-405D-4B8A-84FE-63D958FBACA1

Q33386227-751E10C5-AE7F-4A10-89F2-04232D725F54

P577

Q33386227-CA10A398-C3FB-4BBE-9BC6-2D6F2BB34B4E

P5875

Q33386227-4048EDC7-A2C6-480A-84A8-2F16FB88B508

P6179

Q33386227-9F1925D7-2631-44FF-B2B9-8EED6AB27B64

P698

Q33386227-27075D12-2742-4D01-BB44-E0DC7551B751

P921

Q33386227-4DA72ACE-01C2-4D37-8157-9A44DF943C28

Q33386227-76B65D39-EDAF-4D1C-B361-E410094C50D3

Q33386227-D0C0B5FA-7C63-427E-ABDA-BD7434D0C87A

P932

Q33386227-913DC0E7-748D-4C68-9A54-13069FA910D4

P356

P1433

Cancer Cell International

P1476

Release of volatile organic co ...... cer cell line CALU-1 in vitro.

@en

P2093

Andreas Sponring

http://www.w3.org/2001/XMLSchema#string

Anton Amann

http://www.w3.org/2001/XMLSchema#string

Clemens Ager

http://www.w3.org/2001/XMLSchema#string

Jakob Troppmair

http://www.w3.org/2001/XMLSchema#string

Tomas Mikoviny

http://www.w3.org/2001/XMLSchema#string

P2860

Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study

Volatile markers of breast cancer in the breath.

Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors.

Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production.

13C-breath tests in hepatology (cytosolic liver function).

Breath analysis in critically ill patients: potential and limitations.

Breath analysis: the approach towards clinical applications.

Detection of lung cancer by sensor array analyses of exhaled breath

ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.

Augmented expression of peroxiredoxin I in lung cancer.

P2888

P304

17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2867-8-17

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Wolfram Miekisch

Jochen K. Schubert

Wojciech Filipiak

P577

2008-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23489592

http://www.w3.org/2001/XMLSchema#string

P6179

1039555852

http://www.w3.org/2001/XMLSchema#string

P698

19025629

http://www.w3.org/2001/XMLSchema#string

P921

2,3,3-trimethylpentane

2,3,5-trimethylhexane

volatile organic compound

P932

2639533

http://www.w3.org/2001/XMLSchema#string